Literature DB >> 15466994

Dengue viral infections.

G N Malavige1, S Fernando, D J Fernando, S L Seneviratne.   

Abstract

Dengue viral infections are one of the most important mosquito borne diseases in the world. They may be asymptomatic or may give rise to undifferentiated fever, dengue fever, dengue haemorrhagic fever (DHF), or dengue shock syndrome. Annually, 100 million cases of dengue fever and half a million cases of DHF occur worldwide. Ninety percent of DHF subjects are children less than 15 years of age. At present, dengue is endemic in 112 countries in the world. No vaccine is available for preventing this disease. Early recognition and prompt initiation of appropriate treatment are vital if disease related morbidity and mortality are to be limited. This review outlines aspects of the epidemiology of dengue infections, the dengue virus and its mosquito vector, clinical features and pathogenesis of dengue infections, and the management and control of these infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466994      PMCID: PMC1743110          DOI: 10.1136/pgmj.2004.019638

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  132 in total

1.  Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation.

Authors:  M Juffrie; G M van Der Meer; C E Hack; K Haasnoot; A J Veerman; L G Thijs
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Hepatic dysfunction in childhood dengue infection.

Authors:  B Mohan; A K Patwari; V K Anand
Journal:  J Trop Pediatr       Date:  2000-02       Impact factor: 1.165

3.  Cardiac involvement in Dengue Haemorrhagic Fever.

Authors:  J P Wali; A Biswas; S Chandra; A Malhotra; P Aggarwal; R Handa; N Wig; V K Bahl
Journal:  Int J Cardiol       Date:  1998-03-13       Impact factor: 4.164

4.  Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens.

Authors:  N M Dung; N P Day; D T Tam; H T Loan; H T Chau; L N Minh; T V Diet; D B Bethell; R Kneen; T T Hien; N J White; J J Farrar
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

Review 5.  Dengue hemorrhagic fever: clinical manifestations and management.

Authors:  S K Kabra; Y Jain; T Singhal; V H Ratageri
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

Review 6.  Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas.

Authors:  F P Pinheiro; S J Corber
Journal:  World Health Stat Q       Date:  1997

7.  Dengue virus infection of human T lymphocytes.

Authors:  N A Mentor; I Kurane
Journal:  Acta Virol       Date:  1997-06       Impact factor: 1.162

8.  Preliminary field evaluation of the combined adulticidal, larvicidal, and wall residual activity of ULV-applied bifenthrin against mosquitoes.

Authors:  H L Lee; M S Khadri; Y F Chiang
Journal:  J Vector Ecol       Date:  1997-12       Impact factor: 1.671

9.  The first reported outbreak of dengue hemorrhagic fever in Irian Jaya, Indonesia.

Authors:  A L Richards; R Bagus; S M Baso; G A Follows; R Tan; R R Graham; B Sandjaja; A L Corwin; N Punjabi
Journal:  Am J Trop Med Hyg       Date:  1997-07       Impact factor: 2.345

10.  An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients.

Authors:  P R Young; P A Hilditch; C Bletchly; W Halloran
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

View more
  79 in total

1.  Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability.

Authors:  James F Kelley; Pakieli H Kaufusi; Vivek R Nerurkar
Journal:  Virology       Date:  2011-11-29       Impact factor: 3.616

2.  Association of genetic polymorphisms of IL1β -511 C>T, IL1RN VNTR 86 bp, IL6 -174 G>C, IL10 -819 C>T and TNFα -308 G>A, involved in symptomatic patients with dengue in Brazil.

Authors:  Isaac Farias Cansanção; Ana Paula Santos do Carmo; Robério Dias Leite; Rosana Deyse Ponte Portela; Sérgio de Sá Leitão Paiva Júnior; Valdir de Queiroz Balbino; Silvia Helena Barem Rabenhorst
Journal:  Inflamm Res       Date:  2016-07-19       Impact factor: 4.575

3.  Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines.

Authors:  Raja Mazumder; Zhang-Zhi Hu; C R Vinayaka; Jose-Luis Sagripanti; Simon D W Frost; Sergei L Kosakovsky Pond; Cathy H Wu
Journal:  Virus Genes       Date:  2007-05-17       Impact factor: 2.332

4.  A small-molecule dengue virus entry inhibitor.

Authors:  Qing-Yin Wang; Sejal J Patel; Eric Vangrevelinghe; Hao Ying Xu; Ranga Rao; Deana Jaber; Wouter Schul; Feng Gu; Olivier Heudi; Ngai Ling Ma; Mee Kian Poh; Wai Yee Phong; Thomas H Keller; Edgar Jacoby; Subhash G Vasudevan
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

5.  Total economic cost and burden of dengue in Nicaragua: 1996-2010.

Authors:  Zachary S Wettstein; Michael Fleming; Aileen Y Chang; David J Copenhaver; Angela R Wateska; Sarah M Bartsch; Bruce Y Lee; Rajan P Kulkarni
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

6.  Transient 2(nd) Degree Av Block Mobitz Type II: A Rare Finding in Dengue Haemorrhagic Fever.

Authors:  Ashwini Kumar Nigam; Omkar Singh; Ayush Agarwal; Amit K Singh; Subhash Yadav
Journal:  J Clin Diagn Res       Date:  2015-05-01

7.  Differences in Mortality and Clinical Manifestations of Dengue Hemorrhagic Fever in Taiwan in Different Years: A Comparison for Cases in 2014 and 2015 Epidemics.

Authors:  Ko Chang; Chung-Hao Huang; Ing-Kit Lee; Po-Liang Lu; Chun-Yu Lin; Tun-Chieh Chen; Ping-Chang Lai; Hsiao-Cheng Hsieh; Hsin-Liang Yu; Chih-Hsing Hung; Meng-Chieh Wu; Yi-Ying Chin; Chun-Chi Huang; Deng-Chyang Wu; Yen-Hsu Chen
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

8.  Impact of renal failure on the outcome of dengue viral infection.

Authors:  Mei-Chuan Kuo; Po-Liang Lu; Jer-Ming Chang; Ming-Yen Lin; Jih-Jin Tsai; Yen-Hsu Chen; Ko Chang; Hung-Chun Chen; Shang-Jyh Hwang
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

9.  Antiviral actions of flavanoid-derived compounds on dengue virus type-2.

Authors:  Mudiana Muhamad; Lee Yean Kee; Noorsaadah Abd Rahman; Rohana Yusof
Journal:  Int J Biol Sci       Date:  2010-05-23       Impact factor: 6.580

10.  Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden.

Authors:  Peter J Hotez; Aruna Kamath
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.